Evidence map›Paper›PMID 33742168›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2021

Lifetime risk of stroke stratified by chronic kidney disease and hypertension in the general Asian population: the Ohasama study.

Shingo Nakayama, Michihiro Satoh, Hirohito Metoki, Takahisa Murakami, Kei Asayama, Azusa Hara, Takuo Hirose, Atsuhiro Kanno, Ryusuke Inoue, Megumi Tsubota-Utsugi and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Guideline
  2. Article
  3. Article
  4. Current hypertension epidemiology and contemporary approaches using the "Real-World Evidence Cycle" framework.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  5. Article
  6. Long-term risk of cardiovascular mortality according to age group and blood pressure categories of the latest guideline.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Shingo NakayamaDivision of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Michihiro SatohDivision of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan. satoh.mchr@gmail.com.
Hirohito MetokiDivision of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Takahisa MurakamiDivision of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kei AsayamaTohoku Institute for Management of Blood Pressure, Sendai, Japan.
Azusa HaraDivision of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University, Tokyo, Japan.
Takuo HiroseDivision of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Atsuhiro KannoDivision of Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Ryusuke InoueMedical Information Technology Center, Tohoku University Hospital, Sendai, Japan.
Megumi Tsubota-UtsugiDepartment of Hygiene and Preventive Medicine, Iwate Medical University School of Medicine, Morioka, Japan.
Masahiro KikuyaDepartment of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Takefumi MoriDivision of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Atsushi HozawaDepartment of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Yutaka ImaiTohoku Institute for Management of Blood Pressure, Sendai, Japan.
Takayoshi OhkuboTohoku Institute for Management of Blood Pressure, Sendai, Japan.
Tohoku Medical and Pharmaceutical University · JPTeikyo University · JPIwate Medical University · JPKeio University · JPTohoku Medical Megabank Organization · JPTohoku University · JPTohoku University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lifetime risk (LTR) evaluates the absolute risk of developing a disease during the remainder of one's life. It can be a useful tool, enabling the general public to easily understand their risk of stroke. No study has been performed to determine the LTR of cardiovascular disease in patients with chronic kidney disease (CKD) with or without hypertension; therefore, we performed this study in an Asian population. We followed 1525 participants (66.0% women; age 63.1 years) in the general population of Ohasama, Japan. We defined CKD as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m

Indexed as

HypertensionRenal Insufficiency, ChronicStrokeFemaleHumansJapanMaleMiddle AgedRisk Factorschronic kidney diseaseepidemiologyhypertensionLifetime riskstroke

Identifiers

PMID33742168
OpenAlexW3138870571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.